Glycolysis converts one molecule of glucose into two molecules of pyruvate, producing a net gain of two ATP and two NADH along the way. Those three outputs are the textbook answer, but they barely scratch the surface of what makes glycolysis interesting. The real story lies in what happens to those products afterward and the surprising number of metabolic side roads that branch off the pathway before it even finishes.
Pyruvate, ATP, and NADH
Glycolysis is a ten-step sequence that takes place in the cytoplasm, outside the mitochondria. Glucose, a six-carbon sugar, gets split into two three-carbon molecules of pyruvate. The pathway uses two ATP to get started but produces four ATP by the end, so the net energy gain is two ATP per glucose. Along the way, electrons are stripped from intermediates and loaded onto a carrier molecule called NAD+, converting it into NADH. Two molecules of NADH are generated per glucose, specifically during the sixth step of the pathway, when the enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) transforms its substrate and hands off electrons and a hydrogen to NAD+.1PubMed Central. The Role of Glyceraldehyde-3-Phosphate Dehydrogenases in NADPH Supply in the Oleaginous Filamentous Fungus Mortierella alpina Water molecules are also released, but they rarely get mentioned because they dissolve into the ocean of water already present in the cell.
Two ATP per glucose sounds modest, and it is. Compared to the roughly 30 or more ATP that a cell can extract from the same glucose when it runs the full suite of aerobic metabolism, glycolysis alone captures only a fraction of the energy locked in the sugar. But glycolysis is fast, and it works without oxygen. That speed and flexibility explain why it has survived essentially unchanged for billions of years in nearly every living organism.
Where Pyruvate Goes After Glycolysis
Pyruvate sits at one of the most important metabolic crossroads in the cell. It can be shuttled into the mitochondria for further oxidation, converted to lactate in the cytoplasm, or, in yeast and some bacteria, turned into ethanol and carbon dioxide. The path it takes depends largely on whether oxygen is available and what the cell needs at that moment. Pyruvate is simultaneously the end product of glycolysis, a major fuel for oxidative metabolism, and a branching point for the synthesis of lactate, fatty acids, and amino acids.2PubMed Central. Mitochondrial pyruvate transport: a historical perspective and future research directions
When oxygen is plentiful, pyruvate typically enters the mitochondria through a dedicated transport complex embedded in the inner mitochondrial membrane. Two proteins, MPC1 and MPC2, form a channel that ferries pyruvate across that membrane, which is otherwise impermeable to it.2PubMed Central. Mitochondrial pyruvate transport: a historical perspective and future research directions Once inside, pyruvate is converted to acetyl-CoA, a two-carbon unit that feeds into the citric acid cycle (also called the TCA cycle). From there, the cell extracts far more energy than glycolysis alone could provide.
When oxygen is scarce, or when the cell needs to regenerate NAD+ quickly to keep glycolysis running, pyruvate takes a different route. In animal cells and many bacteria, it gets converted to lactate. In yeast and certain microorganisms, it undergoes alcoholic fermentation instead, producing ethanol and carbon dioxide. Both of these anaerobic routes serve the same essential purpose: they recycle NADH back to NAD+, which the cell needs to keep glycolysis going. Without that recycling step, glycolysis stalls.
Fermentation and the NAD+ Recycling Problem
Your cells face a bookkeeping problem. Glycolysis produces two NADH for every glucose it processes, but the pathway also requires NAD+ to run. If NADH keeps piling up without being converted back to NAD+, the whole system grinds to a halt. Under aerobic conditions, mitochondria handle this by accepting electrons from NADH and passing them down the electron transport chain. But when oxygen is limited, or when mitochondria are absent entirely (as in red blood cells), fermentation steps in as the emergency backup.
In lactic acid fermentation, the enzyme lactate dehydrogenase transfers electrons from NADH to pyruvate, producing lactate and regenerating NAD+. This happens routinely in your muscles during intense exercise, when oxygen delivery can’t keep up with demand. It also happens in bacteria that produce yogurt and sauerkraut.
Alcoholic fermentation follows a slightly different route. In yeast, pyruvate is first decarboxylated by the enzyme pyruvate decarboxylase, producing acetaldehyde and releasing carbon dioxide. Acetaldehyde is then reduced to ethanol, consuming NADH and regenerating NAD+ in the process. Pyruvate decarboxylase is so central to yeast metabolism that inhibiting it causes pyruvate to accumulate and ethanol production to drop.3PubMed Central. Molecular mechanism of ethanol fermentation inhibition via protein tyrosine nitration of pyruvate decarboxylase by reactive nitrogen species in yeast Researchers have even managed to rewire yeast metabolism entirely, deleting the genes for pyruvate decarboxylase and redirecting carbon flow from ethanol production toward fatty acid synthesis, proving just how pivotal that single enzyme is to fermentation.4PubMed. Reprogramming Yeast Metabolism from Alcoholic Fermentation to Lipogenesis
Neither form of fermentation extracts any additional ATP beyond the two already gained in glycolysis. Their entire purpose is to keep the NAD+ supply flowing so that glycolysis itself can continue.
How NADH Reaches the Mitochondria
Under aerobic conditions, the two NADH molecules produced by glycolysis need to get their electrons into the mitochondria, where they can feed the electron transport chain and generate much more ATP. The problem is that NADH itself cannot cross the inner mitochondrial membrane. The membrane is impermeable to both NADH and NAD+.5PubMed. Neuronal and astrocytic shuttle mechanisms for cytosolic-mitochondrial transfer of reducing equivalents: current evidence and pharmacological tools
Cells solve this with indirect shuttle systems. The two main ones are the malate-aspartate shuttle and the glycerol phosphate shuttle. Both accomplish the same basic task: they pass the electrons from cytoplasmic NADH to carrier molecules that can cross the membrane, effectively moving the energy without moving the NADH molecule itself.6PubMed Central. Malate-aspartate shuttle mediates the intracellular ATP levels, antioxidation capacity and survival of differentiated PC12 cells The malate-aspartate shuttle is more energy-efficient because it delivers electrons to the mitochondrial NAD+ pool, preserving their full energy value. The glycerol phosphate shuttle is faster but slightly less efficient, handing electrons to a different carrier inside the mitochondria. Different tissues lean on different shuttles depending on their metabolic needs. The brain, for instance, relies heavily on the malate-aspartate shuttle.5PubMed. Neuronal and astrocytic shuttle mechanisms for cytosolic-mitochondrial transfer of reducing equivalents: current evidence and pharmacological tools
This shuttle step is easy to overlook when learning about glycolysis, but it determines how much ATP the cell actually gets from those two NADH molecules. If the malate-aspartate shuttle carries the electrons, each NADH eventually contributes about two and a half ATP. If the glycerol phosphate shuttle handles them, each NADH yields closer to one and a half ATP. That difference is why the total ATP yield from one glucose is often quoted as a range rather than a single number.
Glycolytic Intermediates as Building Blocks
The final products of glycolysis get most of the attention, but several molecules generated partway through the pathway are just as biologically important. Glycolysis doesn’t exist solely to produce pyruvate and ATP. It also feeds raw materials into other biosynthetic routes.
One of the most significant branches splits off from the upper part of glycolysis. Glucose-6-phosphate, the very first glycolytic intermediate, can be diverted into the pentose phosphate pathway. This parallel route produces ribose-5-phosphate, which cells need to build nucleotides for DNA and RNA, and NADPH, a different electron carrier that fuels biosynthetic reactions like fatty acid and cholesterol synthesis and helps maintain the cell’s antioxidant defenses.7PubMed Central. The pentose phosphate pathway in health and disease Rapidly dividing cells, which need both nucleotides and fatty acids at high rates, tend to divert more glucose into this branch.
Further down the glycolytic pathway, 3-phosphoglycerate serves as the starting material for serine biosynthesis. Serine is a non-essential amino acid, meaning your body can make it rather than relying solely on dietary sources. The enzyme 3-phosphoglycerate dehydrogenase pulls 3-phosphoglycerate out of glycolysis and channels it through a short series of reactions to produce serine.8PubMed Central. The Role of D-3-Phosphoglycerate Dehydrogenase in Cancer Serine then feeds into the production of glycine, cysteine, and one-carbon units used in DNA methylation and nucleotide synthesis. This branching point is regulated by feedback: when serine levels are high enough, the enzyme dials itself down.9PubMed Central. Novel regulatory mechanism of serine biosynthesis associated with 3-phosphoglycerate dehydrogenase in Arabidopsis thaliana
Other glycolytic intermediates serve as precursors for glycerol (used in fat storage) and for various amino acids depending on the organism. The pathway is less a straight highway and more a trunk road with regular off-ramps.
How Cells Keep Glycolysis in Check
A pathway this central to metabolism can’t be allowed to run unchecked. Cells regulate glycolysis at several points, but the most heavily controlled step involves the enzyme phosphofructokinase (PFK), which catalyzes an early irreversible reaction. PFK acts as a gatekeeper: when the cell already has plenty of ATP, ATP itself binds to an inhibitory site on PFK and slows the enzyme down. When energy is low and AMP levels rise, PFK speeds up.
This regulation is surprisingly intricate. In yeast, mutations that eliminate PFK’s sensitivity to ATP inhibition also knock out its ability to respond to other activating signals like AMP and fructose-2,6-bisphosphate.10PubMed. Single point mutations in either gene encoding the subunits of the heterooctameric yeast phosphofructokinase abolish allosteric inhibition by ATP In mammalian PFK, specific amino acids at the tail end of the enzyme are responsible for transmitting the ATP inhibition signal from its binding site to the active site. Citrate, an intermediate from the TCA cycle, enhances this inhibition, creating a feedback loop: when the TCA cycle is well supplied, citrate helps slow glycolysis.11PubMed Central. Identification of C-terminal motifs responsible for transmission of inhibition by ATP of mammalian phosphofructokinase, and their contribution to other allosteric effects
The practical effect is that glycolysis is self-adjusting. A cell flooded with ATP and citrate dials glycolysis down automatically. A cell burning through energy cranks it up. This prevents wasteful glucose consumption when the cell already has what it needs and ensures a rapid response when demand spikes.
Glycolysis in Cancer Cells
One of the more counterintuitive discoveries in cancer biology is that many tumor cells ramp up glycolysis and convert glucose to lactate even when oxygen is abundant and their mitochondria are functioning normally. This behavior, called the Warburg effect, was first observed nearly a century ago and still puzzles researchers.12PubMed Central. The Warburg Effect: How Does it Benefit Cancer Cells? On the surface, it seems wasteful: why settle for two ATP per glucose when oxidative metabolism could yield fifteen times as much?
The emerging explanation is that cancer cells prioritize growth over energy efficiency. Glycolysis, along with its branching pathways, supplies the building blocks that rapidly dividing cells need: ribose for DNA, NADPH for fatty acid synthesis, glycerol for membranes, and amino acid precursors like serine. Converting glucose to lactate at high speed keeps the supply of these intermediates flowing while regenerating NAD+ to sustain the pace.13PubMed Central. Revisiting the Warburg Effect with Focus on Lactate The lactate produced was once seen purely as waste, but evidence now suggests that lactate itself acts as a signaling molecule and fuel source for neighboring cells in the tumor microenvironment.
This reliance on aerobic glycolysis contrasts with normal cells, which typically switch to fermentation only when oxygen is genuinely scarce.14PubMed Central. Phospholipase D-mTOR requirement for the Warburg effect in human cancer cells The distinction is clinically useful: PET scans exploit the Warburg effect by injecting a radioactive glucose analog and watching where it accumulates most aggressively. Tumors light up because they consume glucose at far higher rates than surrounding normal tissue.
Not All Organisms Run the Same Glycolysis
The glycolysis pathway taught in textbooks is technically the Embden-Meyerhof-Parnas (EMP) pathway, and it is overwhelmingly dominant in animals, fungi, and many bacteria. But it is not the only way organisms break down glucose. A significant number of prokaryotes, including many soil and marine bacteria, rely on an alternative called the Entner-Doudoroff (ED) pathway. The ED pathway produces only one ATP per glucose rather than two, which raises an obvious question: why would any organism accept half the energy yield?
The answer appears to involve a tradeoff between energy return and protein investment. The ED pathway requires far less enzymatic protein to achieve the same rate of glucose processing as the EMP pathway.15PubMed Central. Glycolytic strategy as a tradeoff between energy yield and protein cost For organisms that are nutrient-limited rather than energy-limited, spending less protein on glycolytic enzymes can be a net advantage. This logic holds for cyanobacteria and even some plant tissues, which are photosynthesizers awash in light energy but often short on nitrogen and phosphorus for building proteins.16PubMed Central. The Entner-Doudoroff pathway is an overlooked glycolytic route in cyanobacteria and plants
The evolutionary history of glycolysis adds another layer. Recent analyses suggest that the core enzymes of glycolysis originated in an autotrophic context, meaning their earliest function may have been building sugars rather than breaking them down. Glucose breakdown for energy came later, potentially linked to the use of glycogen as a storage molecule.17PubMed Central. The early evolution of the glycolytic pathway from autotrophic origins to glycogen and back The same enzymatic toolkit was then repurposed for energy extraction, which is why gluconeogenesis (the reverse pathway that builds glucose) shares so many enzymes with glycolysis.
Red Blood Cells and a Unique Glycolytic Byproduct
Human red blood cells are unusual because they have no mitochondria. Every bit of ATP they produce comes from glycolysis, making them entirely dependent on the pathway for their energy supply. But red blood cells also generate a glycolytic byproduct found in no other cell type: 2,3-bisphosphoglycerate (2,3-BPG).
2,3-BPG is produced by a side reaction that diverts one of the glycolytic intermediates, 1,3-bisphosphoglycerate, away from the main pathway. Its primary role is to bind hemoglobin and reduce its affinity for oxygen, which helps hemoglobin release oxygen into tissues more readily. Without adequate 2,3-BPG, hemoglobin would hold on to oxygen too tightly and tissue delivery would suffer.
This metabolite also has an inhibitory effect on glycolysis itself. In people with pyruvate kinase deficiency, a genetic disorder that impairs one of the last steps of glycolysis, 2,3-BPG levels rise because the pathway backs up. The combination of reduced ATP and elevated 2,3-BPG is a hallmark of this condition.18Frontiers in Cellular and Infection Microbiology. Synthetic Red Blood Cell-Specific Glycolytic Intermediate 2,3-Diphosphoglycerate (2,3-DPG) Inhibits Plasmodium falciparum Development In Vitro Interestingly, the elevated 2,3-BPG may confer a side benefit: research has explored whether it inhibits the malaria parasite inside red blood cells, since pyruvate kinase deficiency is more common in regions where malaria is endemic. The parasite depends on glycolysis in the red blood cell for its own energy supply, and high 2,3-BPG may interfere with that.
Red blood cells illustrate a broader point about glycolysis. The same pathway that in most cells is merely the opening act for mitochondrial metabolism is, in these cells, the entire show. Every adaptation of red blood cell metabolism, from 2,3-BPG production to the reliance on the pentose phosphate pathway for antioxidant defense, flows from the constraint of having no mitochondria and no alternative to glycolysis for ATP.